JPRN-UMIN000003252招募中2 期
Phase II trial of DIF drug as adjuvant therapy after curative resection of colon cancer - Investigation of risk facter for colon cancer- - Phase II trial of DIF drug as adjuvant therapy after curative resection of colon cancer
Yamaguchi University Department of Srgery and Clinical Science0 个研究点目标入组 120 人开始时间: 2010年3月1日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 120
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Contraindications of using UFT, LV, TS-1 2) active double cancer except ca. in situ 3) Severe postoperative complication 4) Serious coexisting illness a)uncontrolled diabetes mellitus b)uncontrolled hypertension c)history of myocardial infarction, unstable angina within 6 months prior to the registration severe d)liver cirrhosis e)pulmonary dysfunction 5) pregnant or nursing patient or with intent to bear baby 6) mental disorder or psychiatric symptom 7) HIV infection 8) Disqualified by attending doctor
研究者
相似试验
招募中
2 期
Phase II study of neoadjuvant DCF followed by adjvant S-1 for pN+ forn locally advanced esophageal cancer.Esophageal cancerJPRN-jRCTs031180375Seto Yasuyuki110
已完成
不适用
Phase II study of neoadjuvant DCF therapy followed by adjvant S-1 monotherapy for pathological lymph node metastacis cases for locally advanced esophageal cancer.Esophageal cancerJPRN-UMIN000027589The University of Tokyo98
尚未招募
不适用
Phase II study of adjuvant therapy of alternate day oral therapy with S-1 for patients with curative resected biliary tract cancerbiliary tract cancerJPRN-UMIN000021459Gastrointestinal and pediatric surgery Tokyo medical university40
招募中
2 期
eoadjuvant DOS treatment for advanced esophageal cancerEsophageal cancerJPRN-jRCTs041210023Kodera Yasuhiro45
招募中
2 期
A randomized phase II trial of adjuvant immunotherapy with alpha-GalactosylCeramide-pulsed dendritic cells for advanced oropharyngeal and hypopharyngeal cancer following standard therapyOropharyngeal and Hypopharyngeal squamous cell carcinomaJPRN-UMIN000007559Department of Otorhinolaryngology, Head and Neck Surgery, Graduate School of Medicine, Chiba University80